Ondansetron Hydrochloride
Product Images NDC 10544-575

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 10544-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 8mg 6ct (Label Ondansetron Tabs 8mg Bpi(10544 575 06) Aurobindo(65862 188 30) Rev1)

Label 8mg 6ct (Label Ondansetron Tabs 8mg  Bpi(10544 575 06) Aurobindo(65862 188 30) Rev1)
Ondansetron Tablets, USP 8mg, pack of 6 tablets. The label includes NDC 10544-575-06, manufacturer Blenheim Pharmacal, Inc., and storage instructions to keep at controlled room temperature 20°-25°C (68°-77°F) with temporary allowances 15°-30°C (59°-86°F). The packaging states 'Rx Only' and includes multiple peel-off sections with additional labeling.*
FDA Label Image

Structure (Ondansetron Str)

Structure (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride dihydrate, showing the molecular arrangement including an indole ring, a methyl group, a ketone, and an imidazole moiety with associated hydrochloride and water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.